Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange
Stopped Study was stopped due to recruitment failure
Conditions
- Clotting Disorder Due to Plasma Exchange Therapy
- Humoral Rejection After Kidney Transplantation
Sponsor
Hannover Medical School